Cart
sales@molnova.com
Home - Products - Others - Other Targets - Cytochalasin H

Cytochalasin H

CAS No. 53760-19-3

Cytochalasin H( (16-Benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl) acetate )

Catalog No. M24524 CAS No. 53760-19-3

Cytochalasin H is a potent inhibitor of actin incorporation into filaments.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 415 In Stock
2MG 138 In Stock
5MG 226 In Stock
10MG 340 In Stock
25MG 554 In Stock
50MG 719 In Stock
100MG 986 In Stock
200MG 1330 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Cytochalasin H
  • Note
    Research use only, not for human use.
  • Brief Description
    Cytochalasin H is a potent inhibitor of actin incorporation into filaments.
  • Description
    Cytochalasin H is a potent inhibitor of actin incorporation into filaments.
  • In Vitro
    Apoptosis AnalysisCell Line:A549 cells Concentration:0, 6.25, 12.5, 25 and 50 μM Incubation Time:48 h Result:Induced apoptosis in a dose-dependent manner in the A549 cells.Cell Cycle Analysis Cell Line:A549 cells Concentration: 0, 6.25, 12.5, 25 and 50 μM Incubation Time:48 h Result:Arrested cell cycle at the G2/M phase and sub-G1 peaks.Western Blot Analysis Cell Line:A549 cells Concentration:0, 6.25, 12.5, 25 and 50 μM Incubation Time:48 h Result:Increased the protein expression levels of Bax, P53 and cleaved caspase-3 and decreased the protein expression levels of Bcl-xL, Bcl-2 and full-length caspase-3.
  • In Vivo
    Animal Model:male Balb/cnu/nu mice with A549 xenograftDosage:2.5 mg/kg Administration:intraperitoneal injection; 3 injections/week,for 80 days Result:Attenuated tumor growth in vivo.
  • Synonyms
    (16-Benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl) acetate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ET-1|MMP2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    53760-19-3
  • Formula Weight
    493.63
  • Molecular Formula
    C30H39NO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@H]([C@@H]([C@H](Cc1ccccc1)N1)[C@@]([C@H]([C@@H]2O)/C=C/C[C@H](C)C[C@](C)(/C=C3)O)([C@@H]3OC(C)=O)C1=O)C2=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ma Y , Xiu Z , Zhou Z , et al. Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells[J]. Journal of Cancer, 2019, 10(9).
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Falcarindiol

    Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.

  • Methoxyeugenol 4-O-r...

    Methoxyeugenol 4-O-rutinoside (compound 9) is a phenyl glucoside present in Daphniphyllum angustifolium bark.

  • 20-Hydroxylucidenic ...

    20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.

Sign In Join Free